Hot Features
Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.
Imunon Inc is developing new medicines that harness the building blocks of life to work in harmony with the body's immune system. It is a fully integrated, clinical stage biotechnology company focused on advancing a portfolio of innovative treatments that harness the body's natural mechanisms to gen... Imunon Inc is developing new medicines that harness the building blocks of life to work in harmony with the body's immune system. It is a fully integrated, clinical stage biotechnology company focused on advancing a portfolio of innovative treatments that harness the body's natural mechanisms to generate safe, effective, and durable responses across a broad array of human diseases. Mehr anzeigen
Based on more than six months of additional monitoring, data show continued improvement in overall survival (OS) in intent-to-treat (ITT) population of women newly diagnosed with advanced ovarian...
FDA Project Team supports the company’s proposed Phase 3 trial strategy, including overall trial design, target patient population, treatment schedule, and primary endpoint Final Protocol...
IMNN-001 immunotherapy plus standard-of-care chemotherapy resulted in 35% improvement in overall survival and 25% improvement in progression-free survival versus standard-of-care alone Treatment...
Conference call today at 11:00 a.m. ET LAWRENCEVILLE, N.J., Nov. 07, 2024 (GLOBE NEWSWIRE) -- IMUNON, Inc. (NASDAQ: IMNN), a clinical-stage company in late-stage development with its...
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -0.019 | -2.20930232558 | 0.86 | 0.9204 | 0.8202 | 199955 | 0.88369655 | CS |
| 4 | 0.042 | 5.25657071339 | 0.799 | 0.9204 | 0.64 | 201519 | 0.80503104 | CS |
| 12 | -0.309 | -26.8695652174 | 1.15 | 1.21 | 0.64 | 208076 | 0.91997506 | CS |
| 26 | -0.319 | -27.5 | 1.16 | 3.65 | 0.64 | 1572602 | 2.68884805 | CS |
| 52 | -0.0001 | -0.0118891927238 | 0.8411 | 3.65 | 0.48 | 860373 | 2.56755923 | CS |
| 156 | -1.119 | -57.0918367347 | 1.96 | 3.65 | 0.48 | 409069 | 2.50190577 | CS |
| 260 | -1.119 | -57.0918367347 | 1.96 | 3.65 | 0.48 | 409069 | 2.50190577 | CS |
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
